An update on vinpocetine: new discoveries and clinical implications

Y Zhang, J Li, C Yan - European journal of pharmacology, 2018 - Elsevier
Vinpocetine, a derivative of the alkaloid vincamine, has been clinically used in many
countries for treatment of cerebrovascular disorders such as stroke and dementia for more …

Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain

MP Kelly - Cellular signalling, 2018 - Elsevier
Deficits in brain function that are associated with aging and age-related diseases benefit
very little from currently available therapies, suggesting a better understanding of the …

Chemically induced models of Parkinson's disease

T Thirugnanam, K Santhakumar - … and Physiology Part C: Toxicology & …, 2022 - Elsevier
Environmental toxins are harmful substances detrimental to humans. Constant exposure to
these fatal neurotoxins can cause various neurodegenerative disorders. Although …

Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: modulation of histone deacetylase activity

S Sharma, R Taliyan, S Singh - Behavioural brain research, 2015 - Elsevier
Parkinson's disease (PD) is the second most common neurodegenerative disorder. Recent
studies have investigated the involvement of epigenetic modifications in PD. Histone …

Exercise-induced neuroprotection and recovery of motor function in animal models of Parkinson's disease

E Palasz, W Niewiadomski, A Gasiorowska… - Frontiers in …, 2019 - frontiersin.org
Parkinson's disease (PD) is manifested by progressive motor, autonomic, and cognitive
disturbances. Dopamine (DA) synthesizing neurons in the substantia nigra (SN) degenerate …

The emerging role of phosphodiesterases in movement disorders

R Erro, NE Mencacci, KP Bhatia - Movement Disorders, 2021 - Wiley Online Library
Cyclic nucleotide phosphodiesterase (PDE) enzymes catalyze the hydrolysis and
inactivation of the cyclic nucleotides cyclic adenosine monophosphate and cyclic guanosine …

Aberrant complement system activation in neurological disorders

K Ziabska, M Ziemka-Nalecz, P Pawelec… - International journal of …, 2021 - mdpi.com
The complement system is an assembly of proteins that collectively participate in the
functions of the healthy and diseased brain. The complement system plays an important role …

[HTML][HTML] Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease

DA Grow, JR McCarrey, CS Navara - Stem cell research, 2016 - Elsevier
The derivation of dopaminergic neurons from induced pluripotent stem cells brings new
hope for a patient-specific, stem cell-based replacement therapy to treat Parkinson's disease …

Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells

M Höllerhage, C Moebius, J Melms, WH Chiu… - Scientific reports, 2017 - nature.com
Abstract α-synuclein-induced neurotoxicity is a core pathogenic event in neurodegenerative
synucleinopathies such as Parkinson's disease, dementia with Lewy bodies, or multiple …

Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseases

Y **ang, S Naik, L Zhao, J Shi… - Medicinal Research …, 2024 - Wiley Online Library
Neurodegenerative diseases (NDs) cause progressive loss of neuron structure and
ultimately lead to neuronal cell death. Since the available drugs show only limited …